{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:13:49Z","timestamp":1778577229403,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010198","name":"MICINN","doi-asserted-by":"publisher","award":["PID2020-116460RB-I00"],"award-info":[{"award-number":["PID2020-116460RB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23151"],"award-info":[{"award-number":["23151"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmc.2023.117467","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T16:46:08Z","timestamp":1694105168000},"page":"117467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies"],"prefix":"10.1016","volume":"94","author":[{"given":"Paloma","family":"Begines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2509","authenticated-orcid":false,"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-7481","authenticated-orcid":false,"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-7068","authenticated-orcid":false,"given":"Roberto","family":"Ronca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-4937","authenticated-orcid":false,"given":"Camilla","family":"Tavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Luisa Massardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-6993","authenticated-orcid":false,"given":"\u00d3scar","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117467_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1432-1033.1975.tb02449.x","article-title":"The catalytic mechanism of carbonic anhydrase","volume":"59","author":"Steiner","year":"1975","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2023.117467_b0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2023.117467_b0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","article-title":"Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase","volume":"36","author":"Nocentini","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116140","article-title":"Developments of small molecules as inhibitors for carbonic anhydrase isoforms","volume":"39","author":"Buabeng","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0025","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2023.117467_b0030","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2023.117467_b0035","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117467_b0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/gast.1997.v112.pm9024293","article-title":"Carbonic anhydrase IX, MN\/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts","volume":"112","author":"Pastorekova","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmc.2023.117467_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmc.2023.117467_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/molecules28010091","article-title":"Investigation on hydrazonobenzenesulfonamides as human carbonic anhydrase I, II, IX and XII inhibitors","volume":"28","author":"Moi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117467_b0055","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/molehr\/7.7.611","article-title":"Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts","volume":"7","author":"Karhumaa","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bmc.2023.117467_b0060","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/002215540004801203","article-title":"Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors","volume":"48","author":"Parkkila","year":"2000","journal-title":"Histochem Cytochem"},{"key":"10.1016\/j.bmc.2023.117467_b0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cells10040862","article-title":"Hypoxia and extracellular acidification as drivers of melanoma progression and drug resistance","volume":"10","author":"Dratkiewicz","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2023.117467_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"Ebbesen","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0075","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2023.117467_b0080","doi-asserted-by":"crossref","unstructured":"a) Potter CPS, Harris AL. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer. 2003;89:2\u20137. b) Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075\u20137083.","DOI":"10.1038\/sj.bjc.6600936"},{"key":"10.1016\/j.bmc.2023.117467_b0085","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ijc.31607","article-title":"An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo","volume":"143","author":"Von Neubeck","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmc.2023.117467_b0090","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4149\/neo_2018_180819N624","article-title":"High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer","volume":"66","author":"Li","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.bmc.2023.117467_b0095","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3390\/cancers12103018","article-title":"Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated CA XII","volume":"12","author":"Giuntini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2023.117467_b0100","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1021\/jm800964f","article-title":"Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate benzenesulfonamide conjugates","volume":"51","author":"Marques","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0105","doi-asserted-by":"crossref","unstructured":"a) Supuran CT, Winum JY. Designing carbonic anhydrase inhibitors for the treatment of breast cancer. Expert Opin Drug Discovery. 2015;10:591\u2013597. b) Supuran CT, Winum, JY. Carbonic anhydrase IX inhibitors in cancer therapy: an update. Future Med Chem. 2015;7:1407\u20131414. c) Hsieh MJ, Chen KS, Chiou HL, et al. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol. 2010;89:598\u2013606.","DOI":"10.1016\/j.ejcb.2010.03.004"},{"key":"10.1016\/j.bmc.2023.117467_b0110","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.bmc.2023.117467_b0115","unstructured":"British Columbia Cancer Agency and Welichem Biotech Inc. A study of SLC-0111 and gemcitabine for metastatic pancreatic ductal cancer in subjects positive for CAIX (SLC-0111-17-01). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03450018."},{"key":"10.1016\/j.bmc.2023.117467_b0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ctrv.2012.08.004","article-title":"New strategies for targeting the hypoxic tumour microenvironment in breast cancer","volume":"39","author":"Ward","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bmc.2023.117467_b0125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jinorgbio.2004.07.009","article-title":"Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours","volume":"98","author":"Russell-Jones","year":"2004","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2023.117467_b0130","doi-asserted-by":"crossref","first-page":"eabf6033","DOI":"10.1126\/sciadv.abf6033","article-title":"A chemical biology approach reveals a dependency of glioblastoma on biotin distribution","volume":"7","author":"Yoon","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.bmc.2023.117467_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2018.01.001","article-title":"Biotin conjugated organic molecules and proteins for cancer therapy: a review","volume":"145","author":"Maiti","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110071","article-title":"Identification and biotin receptor-mediated activity of a novel seleno-biotin compound that inhibits viability of and induces apoptosis in ovarian cancer cells","volume":"365","author":"Raza","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2023.117467_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106410","article-title":"Biotinylated selenocyanates: Potent and selective cytostatic agents","volume":"133","author":"Rold\u00e1n-Pe\u00f1a","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0150","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide Inhibitors of human carbonic anhydrases designed through a three-tails approach: Improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0155","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.bmcl.2015.04.007","article-title":"Synthesis of Schiff base derivatives of 4-(2-aminoethyl)- benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII","volume":"25","author":"Durgun","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117467_b0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/cbic.200800704","article-title":"On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors","volume":"10","author":"Miyazaki","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2023.117467_b0165","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.3390\/ijms22115482","article-title":"Synthesis, molecular docking analysis and biological evaluations of saccharide-modified thiadiazole sulfonamide derivatives","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117467_b0170","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0175","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0180","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/14756366.2022.2091557","article-title":"Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells","volume":"37","author":"Liguori","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/14756366.2021.2004592","article-title":"Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines","volume":"37","author":"Mussi","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0190","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1021\/ja068359w","article-title":"Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II","volume":"129","author":"Srivastava","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117467_b0195","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1107\/S0907444910006554","article-title":"Atomic resolution studies of carbonic anhydrase II","volume":"66","author":"Behnke","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bmc.2023.117467_b0200","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient Expression and crystallization system of cancer-associated carbonic anhydrase Isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0205","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2023.117467_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.vh.2014.12.003","article-title":"The sodium\/multivitamin transporter: a multipotent system with therapeutic implications","volume":"98","author":"Quick","year":"2015","journal-title":"Vitam Horm"},{"key":"10.1016\/j.bmc.2023.117467_b0215","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-021-04211-w","article-title":"Structure and mechanism of the SGLT family of glucose transporters","volume":"601","author":"Han","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117467_b0220","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1124\/dmd.105.005231","article-title":"The blood-brain barrier sodium-dependent multivitamin transporter: A molecular functional in vitro-in situ correlation","volume":"33","author":"Park","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2023.117467_b0225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2012.06.011","article-title":"Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells","volume":"436","author":"Patel","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmc.2023.117467_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jnc.13092","article-title":"Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6\/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells","volume":"134","author":"Uchida","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117467_b0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/mp0500768","article-title":"Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery","volume":"3","author":"Luo","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2023.117467_b0240","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11095-013-1059-7","article-title":"Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity","volume":"30","author":"Vadlapudi","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2023.117467_b0245","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117467_b0250","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/14756366.2018.1512597","article-title":"Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms","volume":"33","author":"Nocentini","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0255","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bpj.2020.11.011","article-title":"Response to perspectives on the classical enzyme carbonic anhydrase and the search for inhibitors","volume":"120","author":"Angeli","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2023.117467_b0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0265","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0270","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2023.117467_b0275","unstructured":"Schr\u00f6dinger Suite Release 2022-2, Schr\u00f6dinger, LLC, New York, NY, 2022: (a) Maestro v.13.2; (b) Epik, v.6.0; (c) Impact, v.9.5; (d) Macromodel v.13.6, (e) Glide, v.9.5; (f) Prime, v.5.5."},{"key":"10.1016\/j.bmc.2023.117467_b0280","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2023.117467_b0285","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and Reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.bmc.2023.117467_b0290","doi-asserted-by":"crossref","first-page":"2201407","DOI":"10.1080\/14756366.2023.2201407","article-title":"Identification of new 4-(6-oxopyridazin-1-yl)benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights","volume":"38","author":"Badawi","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0295","doi-asserted-by":"crossref","first-page":"2191165","DOI":"10.1080\/14756366.2023.2191165","article-title":"Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors","volume":"38","author":"Astrain-Redin","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111642","article-title":"From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction","volume":"182","author":"Kalinin","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117467_b0305","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:31:26Z","timestamp":1778574686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":61,"alternative-id":["S0968089623003152"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117467","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117467"}}